Relationships Between Acute Generalized Eruptive Pustulosis, Age, Sex, Primary Disease, and Prescription Medications: Further Analysis of the Japanese Adverse Drug Event Report Database

Overview

Journal Heliyon

Specialty Social Sciences

Date 2024 Apr 1

PMID 38560160

Authors

Moe Yamashita

Mika Maezawa

Wataru Wakabayashi

Sakiko Hirofuji

Koumi Miyasaka

Nanaka Ichihara

Yuka Nokura

Kensuke Matsui

Satoshi Nakao

Hiroyuki Tanaka

Mitsuhiro Nakamura

Affiliations

Soon will be listed here.

Abstract

Background: Acute generalized eruptive pustulosis (AGEP) is a rare, but serious, drug-related adverse event. This study aimed to determine the relationships between AGEP and age, sex, primary disease, and prescription medications using a database of adverse drug events, namely, the Japanese Adverse Drug Event Report (JADER) database.

Methods: In this retrospective observational study, we analyzed AGEP reports extracted from the JADER database based on the preferred term for AGEP (code 10048799). We evaluated the effects of causative drugs, underlying diseases, age, and sex. The association between AGEP and prescription drugs was analyzed using the reporting odds ratio and adjusted for covariates using multiple logistic regression. Association rule mining was performed to evaluate the correlation between each combination of factors and AGEP.

Results: Between April 2004 and March 2023, 823,662 reports, including 869 reports on AGEP, were entered in the JADER database. The highest percentage of reports in each age group was in males aged <10 years, and clarithromycin was the most used drug in males aged <10 years. Nasopharyngitis was the most common reason for use, and Kawasaki disease was reported as a reason for use among males under 10 years of age, but not among females.

Conclusions: In boys aged <10 years, attention should be paid to the occurrence of AGEP when prescribing clarithromycin and treating Kawasaki disease.

References

Egberts A, Meyboom R, van Puijenbroek E . Use of measures of disproportionality in pharmacovigilance: three Dutch examples. Drug Saf. 2002; 25(6):453-8. DOI: 10.2165/00002018-200225060-00010. View

Shimada K, Hasegawa S, Nakao S, Mukai R, Matsumoto K, Tanaka M . Adverse event profiles of ifosfamide-induced encephalopathy analyzed using the Food and Drug Administration Adverse Event Reporting System and the Japanese Adverse Drug Event Report databases. Cancer Chemother Pharmacol. 2019; 84(5):1097-1105. DOI: 10.1007/s00280-019-03949-5. View

Sidoroff A, Dunant A, Viboud C, Halevy S, Bouwes Bavinck J, Naldi L . Risk factors for acute generalized exanthematous pustulosis (AGEP)-results of a multinational case-control study (EuroSCAR). Br J Dermatol. 2007; 157(5):989-96. DOI: 10.1111/j.1365-2133.2007.08156.x. View

Vallejo-Yague E, Martinez-De la Torre A, Mohamad O, Sabu S, Burden A . Drug Triggers and Clinic of Acute Generalized Exanthematous Pustulosis (AGEP): A Literature Case Series of 297 Patients. J Clin Med. 2022; 11(2). PMC: 8780223. DOI: 10.3390/jcm11020397. View

van Puijenbroek E, Egberts A, Heerdink E, Leufkens H . Detecting drug-drug interactions using a database for spontaneous adverse drug reactions: an example with diuretics and non-steroidal anti-inflammatory drugs. Eur J Clin Pharmacol. 2001; 56(9-10):733-8. DOI: 10.1007/s002280000215. View

Harpaz R, Chase H, Friedman C . Mining multi-item drug adverse effect associations in spontaneous reporting systems. BMC Bioinformatics. 2010; 11 Suppl 9:S7. PMC: 2967748. DOI: 10.1186/1471-2105-11-S9-S7. View

Chen S, Zhang L, Yang F, Yang L, Yang Y, Chen Z . HLA-A*02:07 Allele Associates with Clarithromycin-Induced Cutaneous Adverse Drug Reactions in Chinese Patients. Basic Clin Pharmacol Toxicol. 2018; 123(3):308-313. DOI: 10.1111/bcpt.13011. View

De A, Das S, Sarda A, Pal D, Biswas P . Acute Generalised Exanthematous Pustulosis: An Update. Indian J Dermatol. 2018; 63(1):22-29. PMC: 5838751. DOI: 10.4103/ijd.IJD_581_17. View

Sussman M, Napodano A, Huang S, Are A, Hsu S, Motaparthi K . Pustular Psoriasis and Acute Generalized Exanthematous Pustulosis. Medicina (Kaunas). 2021; 57(10). PMC: 8538083. DOI: 10.3390/medicina57101004. View

10.

Tanaka M, Hasegawa S, Nakao S, Shimada K, Mukai R, Matsumoto K . Analysis of drug-induced hearing loss by using a spontaneous reporting system database. PLoS One. 2019; 14(10):e0217951. PMC: 6782099. DOI: 10.1371/journal.pone.0217951. View

11.

Yildirim P . Association Patterns in Open Data to Explore Ciprofloxacin Adverse Events. Appl Clin Inform. 2016; 6(4):728-47. PMC: 4704041. DOI: 10.4338/ACI-2015-06-RA-0076. View

12.

Nakao S, Hasegawa S, Shimada K, Mukai R, Tanaka M, Matsumoto K . Evaluation of anti-infective-related -associated colitis using the Japanese Adverse Drug Event Report database. Int J Med Sci. 2020; 17(7):921-930. PMC: 7163355. DOI: 10.7150/ijms.43789. View

13.

Lizardo-Castro G, Guillen-Mejia G . Acute generalized exanthematous pustulosis. Bol Med Hosp Infant Mex. 2022; 79(4):268-273. DOI: 10.24875/BMHIM.21000125. View

14.

Feldmeyer L, Heidemeyer K, Yawalkar N . Acute Generalized Exanthematous Pustulosis: Pathogenesis, Genetic Background, Clinical Variants and Therapy. Int J Mol Sci. 2016; 17(8). PMC: 5000612. DOI: 10.3390/ijms17081214. View

15.

Sauzet O, Carvajal A, Escudero A, Molokhia M, Cornelius V . Illustration of the weibull shape parameter signal detection tool using electronic healthcare record data. Drug Saf. 2013; 36(10):995-1006. DOI: 10.1007/s40264-013-0061-7. View

16.

Miteva L, Kadurina M, Schwartz R . Childhood acute generalized exanthematous pustulosis induced by oral ketoconazole. Acta Dermatovenerol Croat. 2011; 18(4):267-70. View

17.

Agarwal S, Agrawal D . Kawasaki disease: etiopathogenesis and novel treatment strategies. Expert Rev Clin Immunol. 2016; 13(3):247-258. PMC: 5542821. DOI: 10.1080/1744666X.2017.1232165. View

18.

Shimada K, Hasegawa S, Nakao S, Mukai R, Sasaoka S, Ueda N . Adverse reaction profiles of hemorrhagic adverse reactions caused by direct oral anticoagulants analyzed using the Food and Drug Administration Adverse Event Reporting System (FAERS) database and the Japanese Adverse Drug Event Report (JADER).... Int J Med Sci. 2019; 16(9):1295-1303. PMC: 6775265. DOI: 10.7150/ijms.34629. View

19.

Martinez-De la Torre A, van Weenen E, Kraus M, Weiler S, Feuerriegel S, Burden A . A Network Analysis of Drug Combinations Associated with Acute Generalized Exanthematous Pustulosis (AGEP). J Clin Med. 2021; 10(19). PMC: 8509508. DOI: 10.3390/jcm10194486. View

20.

Hatahira H, Hasegawa S, Sasaoka S, Kato Y, Abe J, Motooka Y . Analysis of fall-related adverse events among older adults using the Japanese Adverse Drug Event Report (JADER) database. J Pharm Health Care Sci. 2018; 4:32. PMC: 6296112. DOI: 10.1186/s40780-018-0129-8. View